Local IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infection

Arie Jan Stoppelenburg, Vahid Salimi, Marije Hennus, Maud Plantinga, Ron Huis in 't Veld, Jona Walk, Jenny Meerding, Frank Coenjaerts, Louis Bont, Marianne Boes, Arie Jan Stoppelenburg, Vahid Salimi, Marije Hennus, Maud Plantinga, Ron Huis in 't Veld, Jona Walk, Jenny Meerding, Frank Coenjaerts, Louis Bont, Marianne Boes

Abstract

Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characterized by excessive neutrophil infiltration which contributes to RSV induced pathology. The cytokine IL-17A enhances neutrophil infiltration into virus infected lungs. IL-17A is however best known as an effector of adaptive immune responses. The role of IL-17A in early immune modulation in RSV infection is unknown. We aimed to elucidate whether local IL-17A facilitates the innate neutrophil infiltration into RSV infected lungs prior to adaptive immunity. To this end, we studied IL-17A production in newborns that were hospitalized for severe RSV bronchiolitis. In tracheal aspirates we measured IL-17A concentration and neutrophil counts. We utilized cultured human epithelial cells to test if IL-17A regulates RSV infection-induced IL-8 release as mediator of neutrophil recruitment. In mice we investigated the cell types that are responsible for early innate IL-17A production during RSV infection. Using IL-17A neutralizing antibodies we tested if IL-17A is responsible for innate neutrophil infiltration in mice. Our data show that increased IL-17A production in newborn RSV patient lungs correlates with subsequent neutrophil counts recruited to the lungs. IL-17A potentiates RSV-induced production of the neutrophil-attracting chemokine IL-8 by airway epithelial cells in vitro. Various lung-resident lymphocytes produced IL-17A during early RSV infection in Balb/c mice, of which a local population of CD4 T cells stood out as the predominant RSV-induced cell type. By removing IL-17A during early RSV infection in mice we showed that IL-17A is responsible for enhanced innate neutrophil infiltration in vivo. Using patient material, in vitro studies, and an animal model of RSV infection, we thus show that early local IL-17A production in the airways during RSV bronchiolitis facilitates neutrophil recruitment with pathologic consequences to infant lungs.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Early tracheal aspirate (TA) IL-17A…
Figure 1. Early tracheal aspirate (TA) IL-17A correlates to subsequent airway neutrophilia.
(A) RSV patients in this study were younger than 4 months of age and were included during the innate phase of the immune response. Gender, average age, and duration of RSV disease prior to intubation/inclusion ± SD are shown. (B,C) IL-8 and IL-17A concentrations are elevated in TA of RSV patients compared to uninfected controls. Cytokine levels were determined by multiplex immunoassay from TA that was collected at 5 and 48 hours post-intubation. Data represent 9 patients and 7 controls. (D) TA IL-17A concentration at 5 hours post intubation correlates with neutrophil infiltration at 24 hours post intubation. Neutrophils were detected by flow cytometry and are shown as a percentage of live TA cells (n=8). Each data point represents an individual RSV patient. * denote significance of p

Figure 2. IL-17A and RSV synergistically induce…

Figure 2. IL-17A and RSV synergistically induce IL-8 production by airway epithelial cells.

A549 airway…

Figure 2. IL-17A and RSV synergistically induce IL-8 production by airway epithelial cells.
A549 airway epithelial cells were infected with RSV or UV-inactivated RSV for 24 hours at a multiplicity of infection of 3 and in the presence of IL-17A. (A) IL-8 mRNA levels measured by qPCR. Data represents 3-4 experiments. (B) Concentration of IL-8 in the supernatant of RSV-infected and IL-17A treated A549 cells. Data represents 3-5 experiments. * denote significance of p

Figure 3. High dose RSV infection induces…

Figure 3. High dose RSV infection induces early neutrophil infiltration in BALB/c mice.

(A) Mice…

Figure 3. High dose RSV infection induces early neutrophil infiltration in BALB/c mice.
(A) Mice were infected intranasally with a high dose RSV (107 pfu/mouse) or mock infected (PBS). BAL was collected at 2 and 4 days post infection. (B) High dose RSV infection induces rapid weight loss in BALB/c mice. Relative weight to the start of infection is shown. (C) RSV replicates in mice. Viral loads were determined by qPCR in the a-cellular fraction of the BAL. (D - F) High dose RSV infection causes infiltration of neutrophils into RSV infected mouse lungs. (D) Live BAL cells were counted using a hematocytometer and trypane blue staining. (E) Absolute numbers and (F) percentages of neutrophils were determined by analysis of May-Grünwald/Giemsa stained cytospins. All data represent 4 - 16 mice per group and three independent experiments. ** denote significance p<0.01, **** denote significance of p<0.0001.

Figure 4. CD4 T cells are major…

Figure 4. CD4 T cells are major local producers of IL-17A during early RSV infection.

Figure 4. CD4 T cells are major local producers of IL-17A during early RSV infection.
RSV induces IL-17A production in lung lymphocytes at 2 days post infection. (A) Lung single cell suspensions were harvested at 2 days post infection and stimulated with PMA/Ionomycin for 4 hours prior to intracellular cytokine staining and analysis by flow cytometry. (B) Absolute and relative numbers of IL-17A producing lung lymphocytes. (C-F) Predominantly CD4 T cells are induced to produce IL-17A by RSV infection. Separate bar graphs of the relative IL-17A production by (C) TCRβ+CD4+ T cells, (D) TCRβ+CD4- CD8- (DN) T cells, (E) CD1d-tetramer+ NKT cells, and (F) TCRγδ+ gamma/delta T cells . Absolute numbers represent n=4 control mice and n=3 RSV infected mice from one representative experiment.* denote significance of p

Figure 5. Depletion of IL-17A limits neutrophil…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.

(A) Mice received IP…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.
(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two days prior to RSV infection. Mice were infected with high or low dose RSV and sacrificed 2 days post infection. (B,C) Graphs representing the weight loss of anti-IL-17A treated versus isotype treated mice that were infected with a low or a high dose RSV respectively. (D) Viral loads in the a-cellular fraction of the BAL of high dose RSV infected mice. (E,F) Total BAL cell and absolute neutrophil numbers per ml BAL at day 2 post infection in both isotype and anti-IL-17A treated mice. Data represent 3 mice per group for high dose RSV (107 pfu/mouse) infected mice, and at least 5 mice per group for low dose RSV (106 pfu/mouse) infected mice. (G) Representative scatter plots of CD11b and GR-1 surface stained BAL cells. * denote significance of p<0.05.
Similar articles
References
    1. Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG et al. (2007) CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol 179: 8410-8417. PubMed: 18056387. - PubMed
    1. Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM et al. (2010) A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol 84: 2374-2383. doi:10.1128/JVI.01807-09. PubMed: 20015982. - DOI - PMC - PubMed
    1. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 88: 922-926. doi:10.1136/adc.88.10.922. PubMed: 14500316. - DOI - PMC - PubMed
    1. Yasui K, Baba A, Iwasaki Y, Kubo T, Aoyama K et al. (2005) Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatr Int 47: 190-195. doi:10.1111/j.1442-200x.2005.02039.x. PubMed: 15771699. - DOI - PubMed
    1. Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027. doi:10.1136/thorax.55.12.1023. PubMed: 11083887. - DOI - PMC - PubMed
Show all 41 references
Publication types
MeSH terms
Grant support
This study was funded by the WKZ research fund (grant number R1812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 2. IL-17A and RSV synergistically induce…
Figure 2. IL-17A and RSV synergistically induce IL-8 production by airway epithelial cells.
A549 airway epithelial cells were infected with RSV or UV-inactivated RSV for 24 hours at a multiplicity of infection of 3 and in the presence of IL-17A. (A) IL-8 mRNA levels measured by qPCR. Data represents 3-4 experiments. (B) Concentration of IL-8 in the supernatant of RSV-infected and IL-17A treated A549 cells. Data represents 3-5 experiments. * denote significance of p

Figure 3. High dose RSV infection induces…

Figure 3. High dose RSV infection induces early neutrophil infiltration in BALB/c mice.

(A) Mice…

Figure 3. High dose RSV infection induces early neutrophil infiltration in BALB/c mice.
(A) Mice were infected intranasally with a high dose RSV (107 pfu/mouse) or mock infected (PBS). BAL was collected at 2 and 4 days post infection. (B) High dose RSV infection induces rapid weight loss in BALB/c mice. Relative weight to the start of infection is shown. (C) RSV replicates in mice. Viral loads were determined by qPCR in the a-cellular fraction of the BAL. (D - F) High dose RSV infection causes infiltration of neutrophils into RSV infected mouse lungs. (D) Live BAL cells were counted using a hematocytometer and trypane blue staining. (E) Absolute numbers and (F) percentages of neutrophils were determined by analysis of May-Grünwald/Giemsa stained cytospins. All data represent 4 - 16 mice per group and three independent experiments. ** denote significance p<0.01, **** denote significance of p<0.0001.

Figure 4. CD4 T cells are major…

Figure 4. CD4 T cells are major local producers of IL-17A during early RSV infection.

Figure 4. CD4 T cells are major local producers of IL-17A during early RSV infection.
RSV induces IL-17A production in lung lymphocytes at 2 days post infection. (A) Lung single cell suspensions were harvested at 2 days post infection and stimulated with PMA/Ionomycin for 4 hours prior to intracellular cytokine staining and analysis by flow cytometry. (B) Absolute and relative numbers of IL-17A producing lung lymphocytes. (C-F) Predominantly CD4 T cells are induced to produce IL-17A by RSV infection. Separate bar graphs of the relative IL-17A production by (C) TCRβ+CD4+ T cells, (D) TCRβ+CD4- CD8- (DN) T cells, (E) CD1d-tetramer+ NKT cells, and (F) TCRγδ+ gamma/delta T cells . Absolute numbers represent n=4 control mice and n=3 RSV infected mice from one representative experiment.* denote significance of p

Figure 5. Depletion of IL-17A limits neutrophil…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.

(A) Mice received IP…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.
(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two days prior to RSV infection. Mice were infected with high or low dose RSV and sacrificed 2 days post infection. (B,C) Graphs representing the weight loss of anti-IL-17A treated versus isotype treated mice that were infected with a low or a high dose RSV respectively. (D) Viral loads in the a-cellular fraction of the BAL of high dose RSV infected mice. (E,F) Total BAL cell and absolute neutrophil numbers per ml BAL at day 2 post infection in both isotype and anti-IL-17A treated mice. Data represent 3 mice per group for high dose RSV (107 pfu/mouse) infected mice, and at least 5 mice per group for low dose RSV (106 pfu/mouse) infected mice. (G) Representative scatter plots of CD11b and GR-1 surface stained BAL cells. * denote significance of p<0.05.
Similar articles
References
    1. Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG et al. (2007) CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol 179: 8410-8417. PubMed: 18056387. - PubMed
    1. Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM et al. (2010) A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol 84: 2374-2383. doi:10.1128/JVI.01807-09. PubMed: 20015982. - DOI - PMC - PubMed
    1. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 88: 922-926. doi:10.1136/adc.88.10.922. PubMed: 14500316. - DOI - PMC - PubMed
    1. Yasui K, Baba A, Iwasaki Y, Kubo T, Aoyama K et al. (2005) Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatr Int 47: 190-195. doi:10.1111/j.1442-200x.2005.02039.x. PubMed: 15771699. - DOI - PubMed
    1. Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027. doi:10.1136/thorax.55.12.1023. PubMed: 11083887. - DOI - PMC - PubMed
Show all 41 references
Publication types
MeSH terms
Grant support
This study was funded by the WKZ research fund (grant number R1812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 3. High dose RSV infection induces…
Figure 3. High dose RSV infection induces early neutrophil infiltration in BALB/c mice.
(A) Mice were infected intranasally with a high dose RSV (107 pfu/mouse) or mock infected (PBS). BAL was collected at 2 and 4 days post infection. (B) High dose RSV infection induces rapid weight loss in BALB/c mice. Relative weight to the start of infection is shown. (C) RSV replicates in mice. Viral loads were determined by qPCR in the a-cellular fraction of the BAL. (D - F) High dose RSV infection causes infiltration of neutrophils into RSV infected mouse lungs. (D) Live BAL cells were counted using a hematocytometer and trypane blue staining. (E) Absolute numbers and (F) percentages of neutrophils were determined by analysis of May-Grünwald/Giemsa stained cytospins. All data represent 4 - 16 mice per group and three independent experiments. ** denote significance p<0.01, **** denote significance of p<0.0001.
Figure 4. CD4 T cells are major…
Figure 4. CD4 T cells are major local producers of IL-17A during early RSV infection.
RSV induces IL-17A production in lung lymphocytes at 2 days post infection. (A) Lung single cell suspensions were harvested at 2 days post infection and stimulated with PMA/Ionomycin for 4 hours prior to intracellular cytokine staining and analysis by flow cytometry. (B) Absolute and relative numbers of IL-17A producing lung lymphocytes. (C-F) Predominantly CD4 T cells are induced to produce IL-17A by RSV infection. Separate bar graphs of the relative IL-17A production by (C) TCRβ+CD4+ T cells, (D) TCRβ+CD4- CD8- (DN) T cells, (E) CD1d-tetramer+ NKT cells, and (F) TCRγδ+ gamma/delta T cells . Absolute numbers represent n=4 control mice and n=3 RSV infected mice from one representative experiment.* denote significance of p

Figure 5. Depletion of IL-17A limits neutrophil…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.

(A) Mice received IP…

Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.
(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two days prior to RSV infection. Mice were infected with high or low dose RSV and sacrificed 2 days post infection. (B,C) Graphs representing the weight loss of anti-IL-17A treated versus isotype treated mice that were infected with a low or a high dose RSV respectively. (D) Viral loads in the a-cellular fraction of the BAL of high dose RSV infected mice. (E,F) Total BAL cell and absolute neutrophil numbers per ml BAL at day 2 post infection in both isotype and anti-IL-17A treated mice. Data represent 3 mice per group for high dose RSV (107 pfu/mouse) infected mice, and at least 5 mice per group for low dose RSV (106 pfu/mouse) infected mice. (G) Representative scatter plots of CD11b and GR-1 surface stained BAL cells. * denote significance of p<0.05.
Figure 5. Depletion of IL-17A limits neutrophil…
Figure 5. Depletion of IL-17A limits neutrophil infiltration into RSV-infected lungs.
(A) Mice received IP injections of anti-IL-17A antibody or isotype control antibody upon and two days prior to RSV infection. Mice were infected with high or low dose RSV and sacrificed 2 days post infection. (B,C) Graphs representing the weight loss of anti-IL-17A treated versus isotype treated mice that were infected with a low or a high dose RSV respectively. (D) Viral loads in the a-cellular fraction of the BAL of high dose RSV infected mice. (E,F) Total BAL cell and absolute neutrophil numbers per ml BAL at day 2 post infection in both isotype and anti-IL-17A treated mice. Data represent 3 mice per group for high dose RSV (107 pfu/mouse) infected mice, and at least 5 mice per group for low dose RSV (106 pfu/mouse) infected mice. (G) Representative scatter plots of CD11b and GR-1 surface stained BAL cells. * denote significance of p<0.05.

References

    1. Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG et al. (2007) CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol 179: 8410-8417. PubMed: .
    1. Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM et al. (2010) A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol 84: 2374-2383. doi:10.1128/JVI.01807-09. PubMed: .
    1. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 88: 922-926. doi:10.1136/adc.88.10.922. PubMed: .
    1. Yasui K, Baba A, Iwasaki Y, Kubo T, Aoyama K et al. (2005) Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis. Pediatr Int 47: 190-195. doi:10.1111/j.1442-200x.2005.02039.x. PubMed: .
    1. Hull J, Thomson A, Kwiatkowski D (2000) Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027. doi:10.1136/thorax.55.12.1023. PubMed: .
    1. Houben ML, Coenjaerts FE, Rossen JW, Belderbos ME, Hofland RW et al. (2010) Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol 82: 1266-1271. doi:10.1002/jmv.21771. PubMed: .
    1. Franz A, Adams O, Willems R, Bonzel L, Neuhausen N et al. (2010) Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 48: 239-245. doi:10.1016/j.jcv.2010.05.007. PubMed: .
    1. Halfhide CP, Flanagan BF, Brearey SP, Hunt JA, Fonceca AM et al. (2011) Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis 204: 451-458. doi:10.1093/infdis/jir280. PubMed: .
    1. Janssen R, Bont L, Siezen CL, Hodemaekers HM, Ermers MJ et al. (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196: 826-834. doi:10.1086/520886. PubMed: .
    1. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479-489. doi:10.1038/nri2800. PubMed: .
    1. Bera MM, Lu B, Martin TR, Cui S, Rhein LM et al. (2011) Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J Immunol 187: 4245-4255. doi:10.4049/jimmunol.1101789. PubMed: .
    1. Kallal LE, Hartigan AJ, Hogaboam CM, Schaller MA, Lukacs NW (2010) Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology. J Immunol 185: 4137-4147. doi:10.4049/jimmunol.1000677. PubMed: .
    1. Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB et al. (2005) Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 116: 550-557. doi:10.1016/j.jaci.2005.03.051. PubMed: .
    1. Mukherjee S, Allen RM, Lukacs NW, Kunkel SL, Carson WFFt (2012) STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung. Shock 38: 515-523. doi:10.1097/SHK.0b013e31826f862c. PubMed: .
    1. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP et al. (2011) IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 179: 248-258. doi:10.1016/j.ajpath.2011.03.003. PubMed: .
    1. Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD et al. (2004) Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med 170: 306-312. doi:10.1164/rccm.200301-030OC. PubMed: .
    1. Larrañaga CL, Ampuero SL, Luchsinger VF, Carrión FA, Aguilar NV et al. (2009) Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28: 867-873. doi:10.1097/INF.0b013e3181a3ea71. PubMed: .
    1. Faber TE, Groen H, Welfing M, Jansen KJ, Bont LJ (2012) Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J Med Virol 84: 1084-1088. doi:10.1002/jmv.23291. PubMed: .
    1. van Schaik SM, Enhorning G, Vargas I, Welliver RC (1998) Respiratory syncytial virus affects pulmonary function in BALB/c mice. J Infect Dis 177: 269-276. doi:10.1086/514208. PubMed: .
    1. van de Pol AC, Wolfs TF, van Loon AM, Tacke CE, Viveen MC et al. (2010) Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infection. J Clin Microbiol 48: 3569-3574. doi:10.1128/JCM.00097-10. PubMed: .
    1. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT (2005) Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 300: 124-135. doi:10.1016/j.jim.2005.03.009. PubMed: .
    1. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527. doi:10.1084/jem.194.4.519. PubMed: .
    1. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM et al. (2009) Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182: 3469-3481.
    1. Essilfie AT, Simpson JL, Horvat JC, Preston JA, Dunkley ML et al. (2011) Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLOS Pathog 7: e1002244 PubMed: .
    1. Cheng P, Liu T, Zhou WY, Zhuang Y, Peng LS et al. (2012) Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia. BMC Immunol 13: 38. doi:10.1186/1471-2172-13-38. PubMed: .
    1. Jones CE, Chan K (2002) Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 26: 748-753. doi:10.1165/ajrcmb.26.6.4757. PubMed: .
    1. Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M et al. (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162: 2347-2352. PubMed: .
    1. Roussel L, Houle F, Chan C, Yao Y, Bérubé J et al. (2010) IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 184: 4531-4537. doi:10.4049/jimmunol.0903162. PubMed: .
    1. Fiedler MA, Wernke-Dollries K, Stark JM (1995) Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am J Physiol 269: L865-L872. PubMed: .
    1. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170: 2106-2112. PubMed: .
    1. Song C, Luo L, Lei Z, Li B, Liang Z et al. (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181: 6117-6124. PubMed: .
    1. Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K et al. (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10: 66-74. doi:10.1038/ni.1668. PubMed: .
    1. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R et al. (2008) Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180: 5167-5171. PubMed: .
    1. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20: 353-357. doi:10.1016/j.coi.2008.03.006. PubMed: .
    1. Newcomb DC, Boswell MG, Reiss S, Zhou W, Goleniewska K et al. (2013) IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax, 68: 717–23. PubMed: .
    1. Tanaka S, Yoshimoto T, Naka T, Nakae S, Iwakura Y et al. (2009) Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J Immunol 183: 7523-7530. doi:10.4049/jimmunol.0803828. PubMed: .
    1. Kim JS, Smith-Garvin JE, Koretzky GA, Jordan MS (2011) The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J Exp Med 208: 2201-2207. doi:10.1084/jem.20110680. PubMed: .
    1. Ryzhakov G, Lai CC, Blazek K, To KW, Hussell T et al. (2011) IL-17 boosts proinflammatory outcome of antiviral response in human cells. J Immunol 187: 5357-5362. doi:10.4049/jimmunol.1100917. PubMed: .
    1. Hartupee J, Liu C, Novotny M, Li X, Hamilton T (2007) IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179: 4135-4141. PubMed: .
    1. Sun D, Novotny M, Bulek K, Liu C, Li X et al. (2011) Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 12: 853-860. doi:10.1038/ni.2081. PubMed: .
    1. Vanden Eijnden S, Goriely S, De Wit D, Goldman M, Willems F (2006) Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol 36: 21-26. doi:10.1002/eji.200535467. PubMed: .

Source: PubMed

3
Předplatit